Financial Ratios | Haleos Labs Ltd. | R Wadiwala Securities Pvt Ltd

HALEOS LABS LTD.

NSE : HALEOSLABSBSE : 540679ISIN CODE : INE320X01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE1296.8021.8 (+1.71 %)
PREV CLOSE (Rs.) 1275.00
OPEN PRICE (Rs.) 1314.85
BID PRICE (QTY) 1213.60 (5)
OFFER PRICE (QTY) 1296.75 (5)
VOLUME 6
TODAY'S LOW / HIGH (Rs.)1212.10 1314.85
52 WK LOW / HIGH (Rs.)956.05 1680
NSE1256.403.1 (+0.25 %)
PREV CLOSE( Rs. ) 1253.30
OPEN PRICE (Rs.) 1275.00
BID PRICE (QTY) 1256.50 (2)
OFFER PRICE (QTY) 1284.30 (2)
VOLUME 246
TODAY'S LOW / HIGH(Rs.) 1240.20 1306.30
52 WK LOW / HIGH (Rs.)959.8 1680

Financial Ratios

Select year
ParticularsMar2025Mar2024Mar2023Mar2022Mar2021
Operational & Financial Ratios
   Earnings Per Share (Rs)66.5130.0837.9183.7644.84
   CEPS(Rs)111.5670.3473.32116.7870.84
   DPS(Rs)1.501.501.501.501.50
   Book NAV/Share(Rs)650.15584.84557.71503.53427.40
   Tax Rate(%)28.4735.7431.4322.7030.72
Margin Ratios
   Core EBITDA Margin(%)11.689.218.058.8810.25
   EBIT Margin(%)9.065.936.5510.028.19
   Pre Tax Margin(%)6.792.904.638.426.63
   PAT Margin (%)4.851.873.186.514.59
   Cash Profit Margin (%)8.746.276.199.087.26
Performance Ratios
   ROA(%)4.721.602.987.544.82
   ROE(%)10.033.667.0917.9811.07
   ROCE(%)12.607.429.4418.4212.96
   Asset Turnover(x)0.970.850.941.161.05
   Sales/Fixed Asset(x)1.281.191.562.281.88
   Working Capital/Sales(x)45.3731.6514.0218.8924.17
Efficiency Ratios
   Fixed Capital/Sales(x)0.780.840.640.440.53
   Receivable days56.8152.4440.7131.9234.48
   Inventory Days70.2790.1487.1568.7577.87
   Payable days133.15143.42146.47135.85154.56
Valuation Parameters
   PER(x)16.2422.5713.718.3011.04
   PCE(x)9.689.657.095.956.99
   Price/Book(x)1.661.160.931.381.16
   Yield(%)0.140.220.290.220.30
   EV/Net Sales(x)1.190.990.800.810.76
   EV/Core EBITDA(x)8.198.607.887.806.33
   EV/EBIT(x)11.7014.9910.727.268.39
   EV/CE(x)1.461.100.941.231.05
   M Cap / Sales0.950.670.500.600.56
Growth Ratio
   Net Sales Growth(%)12.67-3.04-9.8631.811.84
   Core EBITDA Growth(%)42.549.88-12.0713.2515.71
   EBIT Growth(%)73.84-14.28-39.7861.2121.94
   PAT Growth(%)196.03-44.38-55.0386.6233.13
   EPS Growth(%)121.15-20.68-54.7386.7933.13
Financial Stability Ratios
   Total Debt/Equity(x)0.430.550.590.510.50
   Current Ratio(x)1.061.071.191.141.10
   Quick Ratio(x)0.610.530.560.550.58
   Interest Cover(x)3.991.963.426.265.26
   Total Debt/Mcap(x)0.260.480.630.370.43